CC
Chirag Chhabildas Meghani
About Chirag Chhabildas Meghani
Data last updated:
Chirag Chhabildas Meghani is a Director at Stockal Securities Private Limited (since 2024) and Designated Partner at Avirahi Pharmaceuticals Llp (since 2020). The companies operate in Financial Services and Chemicals. The largest current company by reported revenue is Stockal Securities Private Limited at ₹1.5 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Stockal Securities Private Limited U67190KA2021PTC145392 | Director | 17 Sep 2024 | 2021 | ₹1.5 Lakh (FY 2023) | Active |
| Avirahi Pharmaceuticals Llp AAT-0240 | Designated Partner | 22 Jul 2020 | 2020 | Active |
Board colleagues of Chirag Chhabildas Meghani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Krishnaprasad Ramanathan | 07209850 | Stockal Securities Private Limited | Director |
| Sitashwa Srivastava | 02746837 | Stockal Securities Private Limited | Officer In Default |
| Mehul Ramniklal Shah | 08805389 | Avirahi Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chirag Chhabildas Meghani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chirag Chhabildas Meghani
Chirag Chhabildas Meghani currently holds 2 directorships: Stockal Securities Private Limited (Director, since 17 Sep 2024, revenue ₹1.5 Lakh (FY 2023)); Avirahi Pharmaceuticals Llp (Designated Partner, since 22 Jul 2020).
Chirag Chhabildas Meghani was first appointed on 22 Jul 2020 as Designated Partner at Avirahi Pharmaceuticals Llp. The most recent appointment on record is 17 Sep 2024 at Stockal Securities Private Limited.
The current boards of Chirag Chhabildas Meghani's companies include Krishnaprasad Ramanathan (Stockal Securities Private Limited), Sitashwa Srivastava (Stockal Securities Private Limited), Mehul Ramniklal Shah (Avirahi Pharmaceuticals Llp).